Boston Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Boston Partners’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-124,809	Closed	-$398K	–	749
2021 Q4	$398K	Buy	+124,809	New	+$420K	﹤0.01%	624

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Boston Partners's BDSI Position: Q1 2022 in Review

Boston Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 124,809 shares — an estimated $398K sold.

Boston Partners first reported a position in BDSI in Q4 2021 and held it in 1 quarter. The position peaked at $398K in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Boston Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Boston Partners sold 124,809 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $398K.
Boston Partners first reported a position in BioDelivery Sciences International, Inc. in Q4 2021 and held it in 1 quarter.
Boston Partners's BioDelivery Sciences International, Inc. position peaked at $398K in Q4 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Boston Partners's 13F filing for Q1 2022, filed 10 May 2022.